Related Experiment Video
Updated: May 19, 2026
06:35
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Increasing MuSK activity delays denervation and improves motor function in ALS mice
María J Pérez-García1, Steven J Burden
1Helen L. and Martin S. Kimmel Center for Biology and Medicine, Skirball Institute of Biomolecular Medicine, NYU Medical School, New York, NY 10016, USA.
Cell Reports
|September 4, 2012
Summary
Increasing MuSK expression in SOD1G93A mice, a model for amyotrophic lateral sclerosis (ALS), delayed muscle denervation and improved motor function. This suggests targeting MuSK may offer therapeutic benefits for ALS patients.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron loss, leading to paralysis and respiratory failure.
- Genetic mutations, such as in SOD1, are linked to familial ALS and can be modeled in mice to study disease mechanisms.
- Motor nerve terminal attachment to muscle is crucial for function and involves retrograde signaling pathways.
Purpose of the Study:
- To investigate if enhancing the retrograde signaling pathway via MuSK can ameliorate disease symptoms in a mouse model of ALS.
- To determine the effects of increased MuSK expression on motor innervation and behavioral function in SOD1G93A mice.
Main Methods:
- Crossed SOD1G93A mutant mice with transgenic mice overexpressing MuSK (a key receptor tyrosine kinase in retrograde signaling).
- Utilized histological analyses to assess motor endplate innervation and neuromuscular junctions.
- Employed behavioral assays to evaluate motor function and disease progression.
Main Results:
- A threefold increase in MuSK expression significantly delayed the onset and reduced the severity of muscle denervation.
- Enhanced MuSK activity improved motor function in SOD1G93A mice for over a month.
- No significant alteration in overall survival was observed, but motor function was preserved longer.
Conclusions:
- Upregulating MuSK activity shows potential for improving motor function in the context of ALS.
- Targeting the retrograde signaling pathway, specifically MuSK, represents a promising therapeutic strategy for ALS.
- Pharmacological enhancement of MuSK could be a viable approach to manage motor deficits in ALS.
